valganciclovir.

Theoretical → Also see TABLE 15 p. 1378

Nabilone → see TABLE 11 p. 1377 (CNS depressant effects)

▶ Nabilone is predicted to increase the risk of cardiovascular

side-effects when given with amfetamines.rTheoretical

Nabumetone → see NSAIDs

Nadolol → see beta blockers, non-selective

Nalmefene

GENERAL INFORMATION Discontinue treatment 1 week before

anticipated use of opioids; if emergency analgesia is required

during treatment, an increased dose of opioid analgesic might

be necessary (monitor for opioid intoxication).

▶ Nalmefene is predicted to decrease the efficacy of opioids.

Avoid.rTheoretical

Naloxegol

▶ Antiarrhythmics (dronedarone) are predicted to increase the

exposure to naloxegol. Adjust naloxegol dose and monitor side

effects, p. 65.oStudy

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to markedly decrease the

exposure to naloxegol. Avoid.oStudy

▶ Antifungals, azoles (fluconazole, isavuconazole, posaconazole)

are predicted to increase the exposure to naloxegol. Adjust

naloxegol dose and monitor side effects, p. 65.oStudy

▶ Antifungals, azoles (itraconazole, ketoconazole, voriconazole) are

predicted to markedly increase the exposure to naloxegol.

Avoid.rStudy

▶ Apalutamide is predicted to decrease the exposure to

naloxegol. Avoid or monitor.oStudy

▶ Aprepitant is predicted to increase the exposure to naloxegol.

Adjust

Study

naloxegol dose and monitor side effects, p. 65.o ▶ Calcium channel blockers (diltiazem, verapamil) are predicted to

increase the exposure to naloxegol. Adjust naloxegol dose and

monitor side effects, p. 65.oStudy

▶ Cobicistat is predicted to markedly increase the exposure to

naloxegol. Avoid.rStudy

▶ Crizotinib is predicted to increase the exposure to naloxegol.

Adjust

Study

naloxegol dose and monitor side effects, p. 65.o ▶ Enzalutamide is predicted to markedly decrease the exposure

to naloxegol. Avoid.oStudy

▶ Grapefruit juice is predicted to increase the exposure to

naloxegol. Avoid.oTheoretical

▶ HIV-protease inhibitors are predicted to markedly increase the

exposure to naloxegol. Avoid.rStudy

▶ Idelalisib is predicted to markedly increase the exposure to

naloxegol. Avoid.rStudy

▶ Imatinib is predicted to increase the exposure to naloxegol.

Adjust

Study

naloxegol dose and monitor side effects, p. 65.o ▶ Macrolides (clarithromycin) are predicted to markedly increase

the exposure to naloxegol. Avoid.rStudy

▶ Macrolides (erythromycin) are predicted to increase the

exposure to naloxegol. Adjust naloxegol dose and monitor side

effects, p. 65.oStudy

▶ Mitotane is predicted to markedly decrease the exposure to

naloxegol. Avoid.oStudy

▶ Netupitant is predicted to increase the exposure to naloxegol.

Adjust

Study

naloxegol dose and monitor side effects, p. 65.o ▶ Nilotinib is predicted to increase the exposure to naloxegol.

Adjust

Study

naloxegol dose and monitor side effects, p. 65.o ▶ Rifampicin is predicted to markedly decrease the exposure to

naloxegol. Avoid.oStudy

▶ St John’s Wort is predicted to decrease the exposure to

naloxegol. Avoid.oTheoretical

Naltrexone

GENERAL INFORMATION Avoid concurrent use of opioids.

Nandrolone

▶ Nandrolone is predicted to increase the anticoagulant effect of

coumarins. Monitor and adjust dose.rTheoretical

1498 Monoclonal antibodies — Nandrolone BNF 78

Interactions | Appendix 1

A1

▶ Nandrolone is predicted to increase the anticoagulant effect of

phenindione. Monitor and adjust dose.rTheoretical

Naproxen → see NSAIDs

Naratriptan → see TABLE 13 p. 1378 (serotonin syndrome)

▶ Naratriptan is predicted to increase the risk of

vasoconstriction when given with ergotamine. Separate

administration by 24 hours.rTheoretical

Natalizumab → see monoclonal antibodies

Nateglinide → see TABLE 14 p. 1378 (antidiabetic drugs)

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to slightly decrease the

exposure to nateglinide.nStudy

▶ Enzalutamide is predicted to slightly decrease the exposure to

nateglinide.nStudy

▶ Leflunomide is predicted to increase the exposure to

nateglinide.oTheoretical

▶ Mitotane is predicted to slightly decrease the exposure to

nateglinide.nStudy

▶ Rifampicin is predicted to slightly decrease the exposure to

nateglinide.nStudy

▶ Teriflunomide is predicted to increase the exposure to

nateglinide.oTheoretical

Nebivolol → see beta blockers, selective

Necitumumab → see monoclonal antibodies

Nefopam → see TABLE 10 p. 1377 (antimuscarinics)

▶ Nefopam is predicted to increase the risk of serious elevations

in blood pressure when given with monoamine-oxidase A and B

inhibitors, irreversible. Avoid.rTheoretical

Nelarabine → see TABLE 15 p. 1378 (myelosuppression)

Neomycin → see TABLE 2 p. 1375 (nephrotoxicity), TABLE 19 p. 1379

(ototoxicity), TABLE 20 p. 1379 (neuromuscular blocking effects)

ROUTE-SPECIFIC INFORMATION Since systemic absorption can

follow topical application, the possibility of interactions

should be borne in mind.

▶ Neomycin decreases the absorption of digoxin.oStudy

▶ Neomycin

o

moderately decreases the exposure to sorafenib.

Study

Neostigmine → see TABLE 6 p. 1376 (bradycardia)

▶ Aminoglycosides are predicted to decrease the effects of

neostigmine.oTheoretical

Nepafenac → see NSAIDs

Netupitant

▶ Netupitant is predicted to increase the exposure to

abemaciclib.oStudy

▶ Netupitant is predicted to increase the exposure to aldosterone

antagonists

Study

(eplerenone). Adjust eplerenone dose, p. 193.r

▶ Netupitant very slightly increases the exposure to alkylating

agents (cyclophosphamide).oStudy

▶ Netupitant is predicted to increase the exposure to alkylating

agents (ifosfamide).oStudy

▶ Netupitant is predicted to increase the exposure to alpha

blockers (tamsulosin).oTheoretical

▶ Netupitant

r

is predicted to increase the exposure to alprazolam.

Study

▶ Netupitant is predicted to increase the exposure to

antiarrhythmics

o

(propafenone). Monitor and adjust dose.

Study

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) are predicted to decrease the exposure

to netupitant. Avoid.rStudy

▶ Antifungals, azoles (itraconazole, ketoconazole, voriconazole) are

predicted to increase the exposure to

Study

netupitant.o ▶ Netupitant is predicted to decrease the exposure to antifungals,

azoles (isavuconazole).oTheoretical

▶ Netupitant is predicted to increase the exposure to

antihistamines, non-sedating (mizolastine).rTheoretical

▶ Netupitant is predicted to increase the exposure to

antihistamines, non-sedating (rupatadine). Avoid.oStudy

▶ Netupitant is predicted to increase the concentration of

antimalarials (piperaquine).rTheoretical

▶ Netupitant

o

is predicted to increase the exposure to axitinib.

Theoretical

▶ Netupitant is predicted to increase the exposure to

bedaquiline. Avoid prolonged use.nTheoretical

▶ Netupitant is predicted to increase the exposure to beta2

agonists (salmeterol).oStudy

▶ Bosentan

o

is predicted to decrease the exposure to netupitant.

Theoretical

▶ Netupitant is predicted to increase the exposure to bosutinib.

Avoid or adjust dose.rTheoretical

▶ Netupitant is predicted to increase the exposure to buspirone.

Use with caution and adjust dose.oStudy

▶ Netupitant is predicted to increase the exposure to

cabozantinib.oTheoretical

▶ Netupitant is predicted to increase the exposure to calcium

channel blockers (amlodipine, felodipine, lacidipine,

lercanidipine, nicardipine, nifedipine, nimodipine). Monitor and

adjust dose.oStudy

▶ Netupitant is predicted to increase the exposure to cariprazine.

Avoid.rStudy

▶ Netupitant

o

is predicted to increase the exposure to ceritinib.

Theoretical

▶ Netupitant is predicted to increase the concentration of

ciclosporin.rStudy

▶ Cobicistat

o

is predicted to increase the exposure to netupitant.

Study

▶ Netupitant is predicted to increase the exposure to

cobimetinib.rTheoretical

▶ Netupitant is predicted to increase the exposure to colchicine.

Adjust colchicine dose with moderate inhibitors of CYP3A4,

p. 1120.rStudy

▶ Netupitant is predicted to increase the exposure to oral

corticosteroids (budesonide).oStudy

▶ Netupitant is predicted to increase the exposure to

corticosteroids (dexamethasone). Adjust dose.oStudy

▶ Netupitant is predicted to increase the exposure to

corticosteroids (fluticasone).oStudy

▶ Netupitant is predicted to increase the exposure to

corticosteroids

o

(methylprednisolone). Monitor and adjust dose.

Study

▶ Netupitant is predicted to slightly increase the exposure to

darifenacin.oStudy

▶ Netupitant

r

is predicted to increase the exposure to dasatinib.

Study

▶ Netupitant increases the risk of QT-prolongation when given

with domperidone. Avoid.rStudy

▶ Netupitant is predicted to increase the exposure to dopamine

receptor agonists (bromocriptine).rTheoretical

▶ Netupitant is predicted to increase the concentration of

dopamine receptor agonists (cabergoline).oAnecdotal

▶ Netupitant is predicted to moderately increase the exposure to

dutasteride.nStudy

▶ Efavirenz

o

is predicted to decrease the exposure to netupitant.

Theoretical

▶ Netupitant

o

is predicted to increase the exposure to eletriptan.

Study

▶ Netupitant is predicted to increase the exposure to eliglustat.

Avoid or adjust dose—consult product literature.rStudy

▶ Netupitant is predicted to moderately increase the exposure to

encorafenib.oStudy

▶ Enzalutamide is predicted to decrease the exposure to

netupitant. Avoid.rStudy

▶ Netupitant is predicted to increase the risk of ergotism when

given with ergometrine.rTheoretical

▶ Netupitant is predicted to increase the risk of ergotism when

given with ergotamine.rTheoretical

▶ Netupitant

o

is predicted to increase the exposure to erlotinib.

Theoretical

▶ Netupitant

o

slightly increases the exposure to etoposide.

Study

▶ Netupitant is predicted to increase the concentration of

everolimus. Avoid or adjust dose.oStudy

▶ Netupitant is predicted to increase the exposure to

fesoterodine. Adjust fesoterodine dose with moderate

inhibitors of CYP3A4 in hepatic and renal impairment, p. 777.

nStudy

BNF 78 Nandrolone — Netupitant 1499

Interactions | Appendix 1

A1

Netupitant (continued)

▶ Netupitant

o

is predicted to increase the exposure to gefitinib.

Theoretical

▶ Netupitant is predicted to increase the concentration of

guanfacine. Adjust guanfacine dose, p. 352.oTheoretical

▶ HIV-protease inhibitors are predicted to increase the exposure

to netupitant.oStudy

▶ Netupitant is predicted to increase the exposure to ibrutinib.

Adjust ibrutinib dose with moderate inhibitors of CYP3A4,

p. 983.rStudy

▶ Idelalisib

o

is predicted to increase the exposure to netupitant.

Study

▶ Netupitant

o

is predicted to increase the exposure to imatinib.

Theoretical

▶ Netupitant

o

is predicted to increase the exposure to irinotecan.

Study

▶ Netupitant is predicted to increase the exposure to ivabradine.

Adjust ivabradine dose, p. 211.rTheoretical

▶ Netupitant is predicted to increase the exposure to ivacaftor.

Adjust ivacaftor p. 293 or tezacaftor with ivacaftor p. 295 dose

with moderate inhibitors of CYP3A4.rStudy

▶ Netupitant

o

is predicted to increase the exposure to lapatinib.

Study

▶ Netupitant is predicted to increase the exposure to lomitapide.

Avoid.oTheoretical

▶ Netupitant is predicted to increase the exposure to lurasidone.

Adjust lurasidone dose, p. 398.oStudy

▶ Macrolides (clarithromycin) are predicted to increase the

exposure to netupitant.oStudy

▶ Netupitant

o

is predicted to increase the exposure to maraviroc.

Study

▶ Netupitant is predicted to increase the exposure to midazolam.

Monitor side effects and adjust dose.rStudy

▶ Netupitant is predicted to increase the exposure to

midostaurin.oTheoretical

▶ Mitotane is predicted to decrease the exposure to netupitant.

Avoid.rStudy

▶ Netupitant is predicted to increase the exposure to naloxegol.

Adjust

Study

naloxegol dose and monitor side effects, p. 65.o ▶ Nevirapine

o

is predicted to decrease the exposure to netupitant.

Theoretical

▶ Netupitant

o

is predicted to increase the exposure to nilotinib.

Theoretical

▶ Netupitant is predicted to increase the exposure to olaparib.

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more